In vivo gadolinium neutron capture therapy using a potentially effective compound (Gd-BOPTA)

Anticancer Research

Volumn 23, Issue 3 B, 2003, Pages 2451-2456

  Matsumura, Akira ^a   Zhang, Tian ^a   Yamamoto, Tetsuya ^a   Yoshida, Fumiyo ^a   Sakurai, Yoshinori ^b   Shimojo, Nobuhiro ^b   Nose, Tadao ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NONE

Author keywords

Contrast agent; Gadolinium; Gd BOPTA; Gd DTPA; MRI; Neutron capture therapy

Indexed keywords

CONTRAST MEDIUM; GADOBENIC ACID; GADOLINIUM PENTETATE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC EMISSION SPECTROMETRY; BRAIN TUMOR; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG UPTAKE; GLIOSARCOMA; NEUTRON CAPTURE THERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SOFT TISSUE TUMOR; SUBCUTANEOUS TISSUE; TREATMENT OUTCOME;

ANIMALS; BRAIN NEOPLASMS; GADOLINIUM DTPA; GLIOSARCOMA; MAGNETIC RESONANCE IMAGING; MEGLUMINE; NEUTRON CAPTURE THERAPY; ORGANOMETALLIC COMPOUNDS; RATS; RATS, INBRED F344;

EID: 0042807625     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Brugger RM and Shih JA: Evaluation of Gadolinium-157 as a neutron capture therapy agent. Strahlenther Onkol 165: 153-156, 1989.
2. Shih JA and Brugger RM: Gadolinium as a neutron capture therapy agent. Med Phys 19: 733-743, 1992.
3. Miller GA, Hertel NE and Wehring BW: Gadolinium neutron capture therapy. Nucl Technol 103: 320-331, 1993.
4. Khokhlov VF, Yashikin PN, Silin DI, Djorova ES and Lawaczek R: Neutron capture therapy with Gd-DTPA in tumor-bearing rats. In: Cancer Neutron Capture Therapy (Mishima Y, ed). New York, Plenum Press. 1996, pp 865-869.
5. Akine Y, Tokita N, Tokuuye K, Satoh M, Churei H, Le Pechoux C, Kobayashi T and Kanda K: Suppression of rabbit VX-2 subcutaneous tumor growth by gadolinium neutron capture therapy. Jpn J Cancer Res 84: 841-843, 1993.
6. Giovagnoni A and Paci E: Liver III: Gadolinium based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg). Magn Reson Clin N Am 4: 61-72, 1996.
7. Schneider G., Kirchin MA, Pirovano G., Colosimo C, Ruscalleda J, Korves M, Salerio I, Noce AL and Spinazzi A: Gadobenate dimeglumine-enhanced magnetic resonance imaging of intracranial metastases: Effect of dose on lesion detection and delineation. J Magn Reson Imaging 14: 525-539, 2001.
8. Zhang T, Matsumura A, Yamamoto T, Yoshida F, Nose T and Shimojo N: Comparison of two brain tumor-localizing MRI agents: GD-BOPTA and GD-DTPA. The study of magnetic resonance imaging and inductively coupled plasma atomic emission spectroscopy with rat brain tumors. AJNR Am J Neuroradiol 23: 15-18, 2002.
9. Cavagna FM, Maggioni F, Castelli PM, Dapra M, Imperatori LG, Lorusso V and Jenkins BG: Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 32: 780-796, 1997.
10. Chimoto T, Sagami F, Tirone P, Moriseti A and Bussi S: General toxicity study of gadobenate dimeglumine formulation (E7155) (1)- Single dose intravenous and intracisternal toxicity study in rats. J Toxicol Sci 24 (suppl 1): 1-6, 1999.
11. Martin RF, D'Cunha G., Pardee M and Allen BJ: Induction of double-strand breaks following neutron capture by DNA-bound 157Gd. Int J Radiat Biol 54: 205-208, 1988.
12. De Stasio G, Casalbore P, Pallini R, Gilert B, Sanita F, Ciotti MT, Rosi G, Festinesi A, Larocca LM, Rinelli A, Perret D, Mogk DW, Perfetti P, Mehta MP and Mercanti D: Gadolinium in human glioblastoma cells for gadolinium neutron capture therapy. Cancer Res 61: 4272-4277, 2001.
13. Pascolo L, Cupelli F, Anelli PL, Lorusso V, Visigalli M, Uggeri F and Tiribelli C: Molecular mechanisms for hepatic uptake of magnetic resonance imaging contrast agents Biochem Biophys Res Commun 257: 746-752, 1999.
14. Pascolo L, Petrovic S, Cupelli F, Bruschi CV, Anelli PL, Lorusso V, Visigalli M, Uggeri F and Tiribelli C: ABC protein transport of MRI contrast agents in canalicular rat liver plasma vesicles and yeast vacuoles. Biochem Biophys Res Commun 282: 60-66, 2001.
15. Decleves X, Fajac A, Lehmann-Che J, Tardy M, Mercier C, Hurbain I, Laplanche JL, Bernaudin JF and Scherrmann TM: Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines. Int J Cancer 98: 173-180, 2002.
16. Gao B, Strieger B, Noe B, Fritschy JM and Meier PJ: Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain. J Histochem Cytochem 47: 1255-1264, 1999.
17. Cavagna FM, Marzola P, Dapra M, Maggioni F, Vicinanza E, Castelli PM, de Haen C, Luchinat C, Wendland MF and Saeed M: Binding of gadobenate dimeglumine to proteins extravasated into interstitial space enhances conspicuity of reperfused infarcts. Invest Radiol 29 (suppl 2): S50-53, 1994.
18. Hossmann KA, Seo K, Szymas J and Wechsler W: Quantitative analysis of experimental peritumoral edema in cats. Adv Neurol 52: 449-458, 1990.
19. Zhang T, Matsumura A, Yamamoto T, Yoshida F, Sakurai Y, Kumada H, Yamamoto K and Nose T: A combination use of boron and gadolinium compounds in in vitro NCT trial. In: Research and Development in Neutron Capture Therapy (Sauerwein W, Moss R, Wittig A, eds). Bologna, Monduzzi Editore. 2002, pp819-824.